Biotech company aims to treat sudden hearing loss with early-stage drug

  • 📰 CBSNews
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 68%

Brasil Notícia Notícia

Brasil Últimas Notícias,Brasil Manchetes

While there isn't a drug on the market to restore hearing, a company called Frequency Therapeutics is testing a potential treatment for the condition commonly known as sudden deafness.

Chris Sopuch has taught at Oakcrest High School in New Jersey for 25 years. But in 2017, Sopuch was almost forced to walk away from his life's work at the age of 48.Immediately, Sopuch knew something was wrong.

"This is for people who are born with healthy hearing, and over time, because of noise pollution — that their hearing, you know, really declines," said company founder and CEO David Lucchino. So Sopuch flew to San Antonio for a trial about 18 months after losing his hearing. A month later, while traveling for a checkup, he had a breakthrough.At the time, Dr. Steven Eliades was overseeing Sopuch's care at the University of Pennsylvania. He said Sopuch had"great improvement" that he attributes to the drug.

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 87. in BR

Brasil Últimas Notícias, Brasil Manchetes